RxDoctor Payments DataLook up a doctor →

Paul Mahoney, MD

Interventional Cardiology · Greenville, NCNPI 1578539201

Payments from drug & device makers

$3,944,690in general payments, 2019–2025

Across 2,646 payments — averaging $1490.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1.6M
  • Abbott$1M
  • Medtronic$905K
  • Boston Scientific$364K
  • Abiomed$56K
  • Essential Medical, Inc.$21K
  • plus $36K from 19 others
$24,094in research payments, 2019–2025

Across 52 payments — averaging $463.34 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$24K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,944,690 in reported general payments places this provider in the 95th percentile of 180 interventional cardiology providers in North Carolina.

See all interventional cardiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$97,934
Medicare patients
205
Services billed
568

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →